ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1089

Intermuscular Adipose Tissue in Patients with Systemic Lupus Erythematosus

Jorge Gamboa1, Daniel Carranza Leon1, Rachelle Crescenzi1, Adriana Marton2, Annette Oeser1, Cecilia Chung1, Jens Titze2, Michelle Ormseth1 and C. Michael Stein1, 1Vanderbilt University Medical Center, Nashville, TN, 2Duke NUS Medical School, Singapore, Singapore

Meeting: ACR Convergence 2020

Keywords: exercise, Fatigue, Muscle Biology, physical activity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Muscle Biology, Myositis & Myopathies Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with systemic lupus erythematosus (SLE) have reduced physical activity and frequently complain of fatigue. Exercise reduces fatigue in patients with SLE; however, the mechanism of the exercise-induced reduction in fatigue is unknown. Exercise also improves muscle quality, particularly by reducing intermuscular adipose tissue (IMAT). To date, no study has evaluated the presence of IMAT in patients with SLE. Thus, in this study, we hypothesize that IMAT is increased in patients with SLE, and it is associated with patient-reported physical activity and fatigue.

Methods: In a cross-sectional study, we evaluated 51 participants (23 patients with SLE and 28 controls). IMAT was evaluated in the calf muscles using sequential T1-weighted and Dixon magnetic resonance images (MRI). Patient-reported physical activity and fatigue were evaluated using visual analog scales.

Results: Patients with SLE and controls were similar in terms of age, sex, race, body mass index (BMI), and renal function (Table 1). Corticosteroid and antihypertensive medication use was higher in patients with SLE than in controls. IMAT accumulation, expressed as the ratio of IMAT area to total muscle size, was significantly higher in patients with SLE than in controls (7.92%, 4.51-13.39%, vs. 2.65%, 1.15-4.61%, median, IQR, p< 0.001, Figure 1). These differences between the groups remained significant after adjustment for age, race, and BMI. Corticosteroid use may affect the accumulation of IMAT, however, in patients with SLE  IMAT accumulation did not differ significantly among corticosteroid users and non users p=0.48. Patient-reported fatigue and physical activity were higher and lower, respectively, in patients with SLE than in controls (Table 1). IMAT was positively correlated with patient-reported fatigue (rho=0.52, p< 0.001) and inversely correlated with patient-reported walking distance (rho=-0.60, p< 0.001). Physical activity may affect IMAT accumulation, however, the difference in IMAT between controls and patients with SLE remains significant after adjusting for the reported physical activity (p=0.015).

Conclusion: Patients with SLE have greater IMAT accumulation than controls. Increased IMAT is associated with greater fatigue and lower physical activity. Future studies should evaluate the effectiveness of interventions that improve muscle quality to alleviate fatigue in patients with SLE.

Table 1

Figure 1


Disclosure: J. Gamboa, None; D. Carranza Leon, None; R. Crescenzi, None; A. Marton, None; A. Oeser, None; C. Chung, None; J. Titze, None; M. Ormseth, None; C. Stein, None.

To cite this abstract in AMA style:

Gamboa J, Carranza Leon D, Crescenzi R, Marton A, Oeser A, Chung C, Titze J, Ormseth M, Stein C. Intermuscular Adipose Tissue in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/intermuscular-adipose-tissue-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intermuscular-adipose-tissue-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology